Natural Compound Blocks New Cancer Cell Energy Pathway Identified

A natural substance derived from ginger has been found to disrupt an emerging energy pathway in cancer cells, offering new possibilities for targeted therapies and cancer treatment strategies.
Researchers from Osaka Metropolitan University have uncovered a promising natural compound that can interfere with a novel energy pathway used by certain cancer cells. The compound, ethyl p-methoxycinnamate, a key component of kencur ginger, was shown to inhibit the production of ATP—the energy molecule vital for cell survival—by disrupting fatty acid synthesis and lipid metabolism. Interestingly, instead of targeting glycolysis, which is the common energy source in cancer cells, this compound affects alternative metabolic routes. When exposed to ethyl p-methoxycinnamate, cancer cells increased glycolytic activity as a survival response, indicating an adaptive mechanism that prevents cell death. These insights expand our understanding of cancer metabolism, particularly the Warburg effect, and open new avenues for therapeutic strategies. The study suggests that targeting fatty acid synthesis pathways could be an effective approach in cancer treatment, especially given the compound's ability to cripple ATP production without inducing apoptosis. The findings highlight the importance of exploring natural substances for novel anti-cancer agents and contribute to the growing field of cancer metabolism research.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Innovative Therapy Targets Complement System to Prevent Sickle Cell Disease Complications
A groundbreaking study reveals that targeting the complement immune pathway could prevent severe complications like acute chest syndrome in sickle cell disease patients, paving the way for new targeted therapies.
A Mathematical Approach Illuminates the Placenta's Function and Significance
Emerging research uses advanced imaging and mathematical modeling to better understand the placenta's role in pregnancy, offering potential for early detection of complications like preeclampsia.
Analyzing Chemical Differences in Prostate Cancer Calcifications to Discover New Diagnostic Markers
A novel study by Keele University investigates chemical variations in prostate cancer calcifications to identify new diagnostic markers, aiming to enhance early detection and treatment strategies.
Innovative Cellular Therapy Transitioning from Cancer Treatment to Autoimmune Disease Management
A pioneering cellular therapy originally designed for cancer is now entering clinical trials to treat autoimmune diseases, offering hope for a potential cure with a single infusion. Sylvester Comprehensive Cancer Center is leading this innovative research that targets B cells involved in both conditions.



